mortality/aging
|
|
• 8-10-week-old mice are sensitive not only to the standard prolonged 16 hour fast before a GTT, but young mice are unable to survive other standard metabolic challenges, such as an insulin tolerance test
• even with half the standard insulin administration for an insulin tolerance test (ITT), 8-10-week-old mice die within 45 min or insulin administration, while 14-20-week-old mice survive the ITT with a reduced insulin administration protocol
|
|
• fewer than the expected number of heterozygotes are obtained
|
adipose tissue
|
|
• the major adipose depots (visceral and subcutaneous) are reduced
|
behavior/neurological
polydipsia
(
J:361120
)
|
|
• mice drink more water
|
|
|
• males eat less than wild-type males in a metabolic cage experiment
|
homeostasis/metabolism
|
|
• low glucose elicits 56% lower glucagon secretion in isolated islets compared to wild-type islets
|
|
|
• mice show reduced serum bicarbonate indicating acidemia
|
hypoglycemia
(
J:361120
)
|
|
• mice at 8-10 weeks of age show a reduced trend towards reduced blood glucose in the fed state and by 2 hours of fasting, blood glucose in lower and remains lower for the entire testing period, indicating hypoglycemia
• however, gluconeogenesis in a pyruvate tolerance test in both the fed and fasting state is similar to that in wild-type mice, inducing an elevation in blood glucose in both states
|
|
|
• mice show a greater increase in serum epinephrine at baseline and in response to hypoglycemia induced by insulin compared to the increase seen in wild-type mice
• however, mice show a similar increase in serum corticosterone levels in response to hypoglycemia induced by insulin as wild-type mice, suggesting that counterregulatory hormone responses remain intact
|
|
|
• both baseline glucagon and the glucagon response to insulin-induced hypoglycemia appears blunted
|
|
|
• insulin levels are lower in both the fasted state and 30 min after a glucose bolus; while both wild-type and mutant mice show an increase in serum insulin after glucose administration, the response is blunted rather than exaggerated in mutants
• however, glucose stimulated insulin secretion from isolated pancreatic islets is similar to wild-type islets
|
|
|
• serum leptin levels are diminished
|
|
|
• mice show elevated blood ketones in the fasted state
|
|
|
• in the glucose tolerance test (GTT), mice at 10-14 weeks of age show normal baseline blood glucose before the bolus but show reduced excursion compared to wild-type mice
|
|
|
• mice show marked glycosuria despite normal renal function
|
|
|
• in an insulin tolerance test, mice fasted for 2 hours show the expected initial drop in blood glucose followed by the subsequent initiation of recovery towards normoglycemia, but blood glucose continues to decrease, despite lowering insulin to 1 unit/kg, suggesting enhanced insulin sensitivity and/or deficient counterregulatory response to hypoglycemia
|
cardiovascular system
|
|
• baseline rate-corrected QT interval (QTc) is prolonged
• injection of the non-selective beta-adrenergic agonist isoproterenol prolongs QTc which remains prolonged 7 min later
|
growth/size/body
|
|
• mice are smaller at weaning and remain smaller into adulthood
|
|
• weights of males and females are lower at 10-12 weeks of age
|
integument
renal/urinary system
|
|
• mice show marked glycosuria despite normal renal function
|
nervous system
|
|
• hippocampal neurons from P2 pups show slower voltage-dependent inactivation than wild-type neurons when using Ba2+ as a charge carrier
• calcium channel currents from smooth muscle cells isolated from the colon show a reduction in voltage-dependent inactivation when using Ba2+ as a charge carrier
• however, isolated pancreatic beta cells show normal non-inactivating calcium channel currents and normal kinetics of voltage-gated calcium channel inactivation
|
endocrine/exocrine glands
|
|
• no histological differences are seen in the adrenal medulla
|
|
|
• low glucose elicits 56% lower glucagon secretion in isolated islets compared to wild-type islets
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| Timothy syndrome | DOID:0060173 |
OMIM:601005 |
J:361120 | |


Analysis Tools